Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009)

Journal of Virological Methods

Volumn 183, Issue 1, 2012, Pages 25-33

  Cabral, Teresa M ^a   Berhane, Yohannes ^b   Schmidt, Lisa ^a   Tracz, Dobryan M ^a   Hole, Kate ^b   Leith, Marsha ^b   Corbett, Cindi R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

Author keywords

H1N1; Influenza virus; Neutralizing monoclonal antibody; Pandemic

Indexed keywords

HEMAGGLUTININ; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CELL STRAIN; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYBRIDOMA; IMMUNIZATION; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPERNATANT; SWINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY;

MUS; ORTHOMYXOVIRIDAE; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 84860575879     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.03.016     Document Type: Article

References (41)

1. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., Naghdaliyev A., Peiris J.S., Shindo N., Soeroso S., Uyeki T.M. Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine 2008, 358:261-273.
2. Arias C.F., Escalera-Zamudio M., Soto-Del Rio M.L., Cobian-Guemes A.G., Isa P., Lopez S. Molecular anatomy of 2009 influenza virus A (H1N1). Archives of Medical Research 2009, 40:643-654.
3. Berhane Y., Ojkic D., Neufeld J., Leith M., Hisanaga T., Kehler H., Ferencz A., Wojcinski H., Cottam-Birt C., Suderman M., Handel K., Alexandersen S., Pasick J. Molecular characterization of pandemic H1N1 influenza viruses isolated from turkeys and pathogenicity of a human pH1N1 isolate in turkeys. Avian Diseases 2010, 54:1275-1285.
4. Berry J.D., Jones S., Drebot M.A., Andonov A., Sabara M., Yuan X.Y., Weingartl H., Fernando L., Marszal P., Gren J., Nicolas B., Andonova M., Ranada F., Gubbins M.J., Ball T.B., Kitching P., Li Y., Kabani A., Plummer F. Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of Virological Methods 2004, 120:87-96.
5. Brownlee G.G., Fodor E. The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. The Philosophical Transactions of the Royal Society of London 2001, 356:1871-1876.
6. Burioni R., Canducci F., Mancini N., Clementi N., Sassi M., De M.D., Diotti R.A., Saita D., Sampaolo M., Sautto G., Pianezze M., Clementi M. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV). Virology 2010, 399:144-152.
7. Caton A.J., Brownlee G.G., Yewdell J.W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982, 31:417-427.
8. Cinatl J., Michaelis M., Doerr H.W. The threat of avian influenza A (H5N1). Part I. Epidemiologic concerns and virulence determinants. Medical Microbiology and Immunology 2007, 196:181-190.
9. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England Journal of Medicine 2009, 360:2605-2615.
10. Fraser C., Donnelly C.A., Cauchemez S., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., Griffin J., Baggaley R.F., Jenkins H.E., Lyons E.J., Jombart T., Hinsley W.R., Grassly N.C., Balloux F., Ghani A.C., Ferguson N.M., Rambaut A., Pybus O.G., Lopez-Gatell H., Alpuche-Aranda C.M., Chapela I.B., Zavala E.P., Guevara D.M., Checchi F., Garcia E., Hugonnet S., Roth C. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009, 324:1557-1561.
11. Frey G., Chen J., Rits-Volloch S., Freeman M.M., Zolla-Pazner S., Chen B. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nature Structural & Molecular Biology 2010, 17:1486-1491.
12. Gamblin S.J., Skehel J.J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. Journal of Biological Chemistry 2010, 285:28403-28409.
13. Gerhard W. The role of the antibody response in influenza virus infection. Current Topics in Microbiology and Immunology 2001, 260:171-190.
14. Gerhard W., Yewdell J., Frankel M.E., Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981, 290:713-717.
15. Grandea A.G., Olsen O.A., Cox T.C., Renshaw M., Hammond P.W., Chan-Hui P.Y., Mitcham J.L., Cieplak W., Stewart S.M., Grantham M.L., Pekosz A., Kiso M., Shinya K., Hatta M., Kawaoka Y., Moyle M. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:12658-12663.
16. Gubbins M.J., Berry J.D., Corbett C.R., Mogridge J., Yuan X.Y., Schmidt L., Nicolas B., Kabani A., Tsang R.S. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen. FEMS Immunology and Medical Microbiology 2006, 47:436-443.
17. Igarashi M., Ito K., Yoshida R., Tomebechi D., Kida H., Takada A. Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLOS One 2010, 5:e8553.
18. Kobinger G.P., Meunier I., Patel A., Pillet S., Gren J., Stebner S., Leung A., Neufeld J.L., Kobasa D., von M.V. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. Journal of Infectious Diseases 2010, 201:1000-1006.
19. Kubota-Koketsu R., Mizuta H., Oshita M., Ideno S., Yunoki M., Kuhara M., Yamamoto N., Okuno Y., Ikuta K. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochemical and Biophysical Research Communications 2009, 387:180-185.
20. Madeley C.R., Peiris J.S. Methods in virus diagnosis: immunofluorescence revisited. Journal of Clinical Virology 2002, 25:121-134.
21. Martinez O., Tsibane T., Basler C.F. Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery. International Reviews of Immunology 2009, 28:69-92.
22. McQuillin J., Madeley C.R., Kendal A.P. Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections by immunofluorescence. Lancet 1985, 2:911-914.
23. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
24. Nfon C.K., Berhane Y., Hisanaga T., Zhang S., Handel K., Kehler H., Labrecque O., Lewis N.S., Vincent A.L., Copps J., Alexandersen S., Pasick J. Characterization of H1N1 swine influenza viruses circulating in Canadian pigs in 2009. Journal of Virology 2011, 85:8667-8679.
25. Nobusawa E., Aoyama T., Kato H., Suzuki Y., Tateno Y., Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991, 182:475-485.
26. Pappaioanou M. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?. Comparative Immunology, Microbiology and Infectious Diseases 2009, 32:287-300.
27. Postel A., Ziller M., Rudolf M., Letzel T., Ehricht R., Pourquier P., Dauber M., Grund C., Beer M., Harder T.C. Broad spectrum reactivity versus subtype specificity-trade-offs in serodiagnosis of influenza A virus infections by competitive ELISA. Journal of Virological Methods 2011, 173:49-59.
28. Prabhu N., Prabakaran M., Ho H.T., Velumani S., Qiang J., Goutama M., Kwang J. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. Journal of Virology 2009, 83:2553-2562.
29. Puck J.M., Glezen W.P., Frank A.L., Six H.R. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. Journal of Infectious Diseases 1980, 142:844-849.
30. Skehel J.J., Bizebard T., Bullough P.A., Hughson F.M., Knossow M., Steinhauer D.A., Wharton S.A., Wiley D.C. Membrane fusion by influenza hemagglutinin. Cold Spring Harbor Symposia on Quantitative Biology 1995, 60:573-580.
31. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual Review of Biochemistry 2000, 69:531-569.
32. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125.
33. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nature Structural & Molecular Biology 2009, 16:265-273.
34. Vareckova E., Mucha V., Kostolansky F., Gubareva L.V., Klimov A. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes. Virus Research 2008, 132:181-186.
35. Webster R.G. 1918 Spanish influenza: the secrets remain elusive. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1164-1166.
36. World Health Organization. Influenza (Seasonal)-Factsheet No. 211, 2009.
37. World Health Organization. Pandemic (H1N1) 2009-update (28 May 2010). 2010. 8-5-2010.
38. Wright P., Neumman G., Kawaoka Y. Orthomyxoviruses. Fields Virology 2006, 1691-1740. Lippincott Williams & Wilkins, Philadelphia. D. Knipe, P. Howley (Eds.).
39. Yang M., Berhane Y., Salo T., Li M., Hole K., Clavijo A. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein. Journal of Virological Methods 2008, 147:265-274.
40. Yang M., Clavijo A., Graham J., Salo T., Hole K., Berhane Y. Production and diagnostic application of monoclonal antibodies against influenza virus H5. Journal of Virological Methods 2009, 162:194-202.
41. Yoshida R., Igarashi M., Ozaki H., Kishida N., Tomabechi D., Kida H., Ito K., Takada A. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathogens 2009, 5:e1000350.